BMYB34:BVMF
Bristol-Myers Squibb Company BDR
331,90 R$
arrow_upward
+0,65%(+2,15) 1D
30 სექ, 11:31:25 GMT-3 · BRL
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BMYB34...
Mkt. cap
120,21 მლრ.
Avg. vol.
10,00
Volume
0,00
52-wk high
347,15 R$
52-wk low
221,72 R$
Shares outstanding
2,04 მლრდ.
No. of employees
32 ათ.
Mkt. cap
120,21 მლრ.
Avg. vol.
10,00
Volume
0,00
52-wk high
347,15 R$
52-wk low
221,72 R$
Shares outstanding
2,04 მლრდ.
No. of employees
32 ათ.
News stories
From web sources and news partners
TradingKey
·
3 საათის წინ
Bristol-Myers Squibb Co Stock (BMY) Moved Down by 3.56% on Oct 5: What Investors Need To Know
Yahoo Finance UK
·
3 საათის წინ
Bristol-Myers Squibb shares slide as Leerink Partners downgrades on pipeline doubt
CNBC
·
3 საათის წინ
Cramer’s Stop Trading: Bristol Myers
Investing.com
·
3 საათის წინ
Why is Bristol-Myers Squibb stock sliding today?
Profile
Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb, is an American multinational pharmaceutical company headquartered in Princeton, New Jersey. The company's primary products are apixaban for people with atrial fibrillation; nivolumab, used to treat certain types of cancer; lenalidomide, used to treat multiple myeloma, smoldering myeloma, and myelodysplastic syndromes; abatacept, used to treat autoimmune diseases such as rheumatoid arthritis; pomalidomide, an anti-cancer medication used for the treatment of multiple myeloma and AIDS-related Kaposi sarcoma; ipilimumab, to treat cancer; and luspatercept for the treatment of anemia in beta thalassemia and myelodysplastic syndromes. In 2025, 69% of the company's revenues came from the United States.
The company is ranked 94th on the Fortune 500 and 173rd on the Forbes Global 2000. Wikipedia
About Bristol-Myers Squibb Company BDR
CEOქრის ბერნერი
Employees32,5 ათ.
Founded1887
Headquartersნიუ-იორკი, ნიუ-იორკის შტატი, ამერიკის შეერთებული შტატები
SectorPharmaceutical industry
Websitebms.com